If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Regulatory News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 Dec 2013 09:51

RNS Number : 7939U
Akers Biosciences, Inc.
05 December 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Akers Bioscience, ISIN US00973E1029

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Commerzbank AG

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29 November 2013

6. Date on which issuer notified:

3 December 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

US00973E1029

18,438,500

18,438,500

115,566

115,566

5.47

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

115,566

5.47%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Louise Reid

15. Contact telephone number:

020 7475 5881

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGQCPUPWUBA
Date   Source Headline
25th Jul 20074:42 pmRNSDirector/PDMR Shareholding
25th Jul 20072:54 pmRNSDirector/PDMR Shareholding
18th Jul 20077:01 amRNSDirector/PDMR Shareholding
18th Jul 20077:00 amPRNDirector Shareholding - Restatement
17th Jul 20077:00 amPRNAppointment of CFO
6th Jul 200712:35 pmPRNIssue of Equity
3rd Jul 20077:00 amPRNDirector/PDMR Shareholding
29th Jun 20071:27 pmRNSAnnual Report and Accounts
29th Jun 20078:26 amRNSDirector/PDMR Shareholding
26th Jun 20077:00 amPRNFinal Results
3rd May 20077:00 amPRNUnited States Military Contract
26th Mar 20077:00 amPRNUK Distribution Agreement
22nd Mar 20077:00 amPRNUK Orders
15th Mar 20077:00 amPRNDirectorate Change
14th Mar 20073:52 pmRNSAdditional Listing
9th Mar 20073:14 pmRNSAdditional Listing
20th Feb 20077:00 amPRNStrategic Update
6th Feb 20079:17 amRNSAdditional Listing
1st Feb 20077:00 amPRNDirector Share Purchase
24th Jan 20077:00 amPRNAcquisition
18th Jan 20077:00 amPRNTrading & Product Update
3rd Jan 20074:40 pmRNSDirector/PDMR Shareholding
21st Dec 200611:52 amRNSTotal Voting Rights
14th Dec 20067:00 amPRNExpansion of Home Diagnostic Product Line
10th Nov 20062:27 pmRNSIssue of Equity
30th Oct 20067:00 amPRNDistribution Agreement
24th Oct 20069:36 amRNSIssue of Equity
20th Oct 20063:32 pmRNSAdditional Listing
11th Oct 20067:00 amPRNU.S. Department of Transport Approval
4th Sep 200611:18 amRNSAdditional Listing
23rd Aug 20064:43 pmRNSAdditional Listing
4th Aug 20064:24 pmRNSAdditional Listing
30th Jun 20064:50 pmRNSAnnual Report and Accounts
11th May 20067:00 amPRNDirectorate Change
10th May 20067:00 amPRNResult of AGM
3rd May 20067:00 amPRNFDA Clearance for Rapid Alcohol Breathalyzers
24th Apr 20064:00 pmRNSHolding(s) in Company
4th Apr 20067:00 amPRNFinal Results
3rd Apr 20061:09 pmPRNMajor Distribution Agreement
3rd Mar 20064:03 pmRNSAdditional Listing
28th Feb 20067:00 amPRNAcquisition of WNCK, Inc.
13th Feb 20067:00 amPRNTrading Update
3rd Feb 200612:52 pmRNSAdditional Listing
30th Jan 200610:41 amRNSHolding(s) in Company
27th Jan 20061:34 pmRNSIssue of Equity
3rd Jan 20067:00 amPRNRe. Increased Production Facilities
28th Dec 20053:30 pmRNSHolding(s) in Company
19th Dec 20059:53 amRNSIssue of Equity
9th Dec 20055:46 pmRNSDirector/PDMR Shareholding
30th Nov 200511:27 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.